Cargando…
Liver in the limelight in the corona (COVID-19) time
The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from patho...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457103/ https://www.ncbi.nlm.nih.gov/pubmed/32913847 http://dx.doi.org/10.12998/wjcc.v8.i16.3405 |
_version_ | 1783575935442747392 |
---|---|
author | Chela, Harleen Kaur Pasha, Syed Bilal Basar, Omer Daglilar, Ebubekir Tahan, Veysel |
author_facet | Chela, Harleen Kaur Pasha, Syed Bilal Basar, Omer Daglilar, Ebubekir Tahan, Veysel |
author_sort | Chela, Harleen Kaur |
collection | PubMed |
description | The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from pathogenesis, host related factors and the variable effect it has on different patient populations. Though it has claimed fame due to its ability to compromise the respiratory system, it possess the capability to infect other organs as well including the liver. It is important for clinicians to recognize that the virus can result in multi-organ dysfunction as well. Presentation with gastrointestinal symptoms and involvement of the liver can be subtle and can be misdiagnosed. Those with pre-existing liver disease may be more susceptible as well as those who are immunosuppressed or have other co-morbidities. This review article provides a brief overview of some of the information that is available so far with regards to how the liver is impacted by the coronavirus. |
format | Online Article Text |
id | pubmed-7457103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-74571032020-09-09 Liver in the limelight in the corona (COVID-19) time Chela, Harleen Kaur Pasha, Syed Bilal Basar, Omer Daglilar, Ebubekir Tahan, Veysel World J Clin Cases Minireviews The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from pathogenesis, host related factors and the variable effect it has on different patient populations. Though it has claimed fame due to its ability to compromise the respiratory system, it possess the capability to infect other organs as well including the liver. It is important for clinicians to recognize that the virus can result in multi-organ dysfunction as well. Presentation with gastrointestinal symptoms and involvement of the liver can be subtle and can be misdiagnosed. Those with pre-existing liver disease may be more susceptible as well as those who are immunosuppressed or have other co-morbidities. This review article provides a brief overview of some of the information that is available so far with regards to how the liver is impacted by the coronavirus. Baishideng Publishing Group Inc 2020-08-26 2020-08-26 /pmc/articles/PMC7457103/ /pubmed/32913847 http://dx.doi.org/10.12998/wjcc.v8.i16.3405 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Chela, Harleen Kaur Pasha, Syed Bilal Basar, Omer Daglilar, Ebubekir Tahan, Veysel Liver in the limelight in the corona (COVID-19) time |
title | Liver in the limelight in the corona (COVID-19) time |
title_full | Liver in the limelight in the corona (COVID-19) time |
title_fullStr | Liver in the limelight in the corona (COVID-19) time |
title_full_unstemmed | Liver in the limelight in the corona (COVID-19) time |
title_short | Liver in the limelight in the corona (COVID-19) time |
title_sort | liver in the limelight in the corona (covid-19) time |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457103/ https://www.ncbi.nlm.nih.gov/pubmed/32913847 http://dx.doi.org/10.12998/wjcc.v8.i16.3405 |
work_keys_str_mv | AT chelaharleenkaur liverinthelimelightinthecoronacovid19time AT pashasyedbilal liverinthelimelightinthecoronacovid19time AT basaromer liverinthelimelightinthecoronacovid19time AT daglilarebubekir liverinthelimelightinthecoronacovid19time AT tahanveysel liverinthelimelightinthecoronacovid19time |